This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Gitt AK, Zeymer U, Zahn R, Hochadel M, Bauer T, Weidinger F, Seabra-Gomes R, Wijns W, Serruys P, Marco J, Euro Heart Survey Investigators.Underuse of GP IIb/IIIa receptor blocker in high risk diabetics with NSTE-ACS in clinical practice in Europe: lessons from the euro heart survey PCI registry. ESC Congress 2008: Annual Congress of the European Society of Cardiology: abstr. P2044, 30 Aug 2008. Available from: URL: http://www.escardio.org
Rights and permissions
About this article
Cite this article
Only a fraction of patients with diabetes mellitus undergoing PCI* for NSTE-ACS** in Europe receive GPIIb-IIIa antagonists,. Pharmacoecon. Outcomes News 561, 7 (2008). https://doi.org/10.2165/00151234-200805610-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805610-00014